Pharming Group N.V. (ENXTAM:PHARM) is looking acquisitions. During the company?s first half 2023 results call, Jeroen Wakkerman, Chief Financial Officer said that ?We continue to look at investments on acquisitions and in-licensing of mid- to late-stage opportunities in rare diseases to build the company further?.